Summary
A randomized controlled trial (RCT) comparing primary-care-centred follow-up of breast cancer patients with the current standard practice of specialist-centred follow-up showed no increase in delay in diagnosing recurrence, and no increase in anxiety or deterioration in health-related quality of life. An economic evaluation of the two schemes of follow-up was conducted concurrent with the RCT. Because the RCT found no difference in the primary clinical outcomes, a cost minimization analysis was conducted. Process measures of the quality of care such as frequency and length of visits were superior in primary care. Costs to patients and to the health service were lower in primary care. There was no difference in total costs of diagnostic tests, with particular tests being performed more frequently in primary care than in specialist care. Data are provided on the average frequency and length of visits, and frequency of diagnostic testing for breast cancer patients during the follow-up period.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Breast Cancer Surveillance Expert Panel (1997). Recommended breast cancer surveillance guidelines. J Clin Oncol 15: 2149–2156.
Clark, P. B. & Morris, D. L. (1981). Management of patients after mastectomy. Br Med J 282: 2095–2096.
Dewar, J. (1995). Follow-up in breast cancer: a suitable case for reappraisal. Br Med J 310: 685–686.
Donegan, W. L. (1995). Follow-up after treatment for breast cancer: how much is too much? J Surg Oncol 59: 211–214.
Drummond, M. F. & Davies, L. M. (1991). Economic analysis alongside clinical trials. Int J Technol Assess Health Care 7: 561–573.
Drummond, M. F. & Jefferson, T. O. (1996). Guidelines for authors and peer reviewers of economic submissions to the BMJ. Br Med J 313: 275–283.
Drummond, M. F., O’Brien, B., Stoddart, G. L. & Torrance, G. W. (1997). Methods for the Economic Evaluation of Health Care Programmes, 2nd edn. Oxford University Press: Oxford
Garner, S. B., Winter, P. D. & Garner, M. J. (1991). CIA statistical program version 1.1,
GIVIO Investigators (1994). Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. JAMA 271: 1587–1592.
Grunfeld, E., Mant, D., Yudkin, P., Adewuyi-Dalton, R., Cole, D., Stewart, J., Fitzpatrick, R. & Vessey, M. P. V. (1996). Routine follow-up of breast cancer in primary care: a randomised trial. Br Med J 313: 665–669.
Health Services Research Group (1992). Quality of care. 1. What is quality and how can it be measured? Can Med Assoc J 146: 2153–2158.
Hughes, L. E. & Courtney, S. P. (1985). Follow-up of patients with breast cancer. Br Med J 290: 1229–1230.
Loprinzi, C. (1995). Follow-up testing for curatively treated cancer survivors. JAMA 273: 1877–1878.
Mapelli, V., Dirindin, N. & Grilli, R. (1995). Economic evaluation of diagnostic follow-up after primary treatment for breast cancer. Ann Oncol 6: S61–S64.
McWhinney, I. R., Hoddinott, S. N., Bass, M. J., Gay, K. & Shearer, R. (1990). Role of the family physician in the care of cancer patients. Can Fam Phys 36: 2183–2186.
Robinson, R. (1993). Costs and cost-minimisation analysis. Br Med J 307: 726–728.
Rosselli Del Turco, M., Palli, D., Cariddi, A., Ciatto, S., Pacini, P. & Distante, V. (1994). Intensive diagnostic follow-up after treatment of primary breast cancer. JAMA 271: 1593–1597.
Schapira, D. V. (1993). Breast cancer surveillance – a cost-effective strategy. Breast Cancer Res Treat 25: 107–111.
Sculpher, M. J. & Buxton, M. J. (1993). The Private Costs Incurred when Patients Visit Screening Clinics: The Cases of Screening for Breast Cancer and for Diabetic Retinopathy. pp. 1–18, Health Economics Group: Brunel University
Strayer, F., Kisker, C. T. & Fethke, C. (1980). Cost-effectiveness of a shared management delivery system for the care of children with cancer. Pediatrics 66: 907–911.
Tomin, R. & Donegan, W. L. (1987). Screening for recurrent breast cancer – its effectiveness and prognostic value. J Clin Oncol 5: 62–67.
Virgo, K. S., Vernava, A. M., Longo, W. E., McKirgan, L. W. & Johnson, F. E. (1995). Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 273: 1837–1841.
Wilson, A. (1991). Consultation length in general practice: a review. Br J Gen Pract 41: 119–122.
Worster, A., Wood, M. L., McWhinney, I. R. & Bass, M. J. (1995). Who provides follow-up care for patients with breast cancer? Can Fam Phys 41: 1314–1319.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Grunfeld, E., Gray, A., Mant, D. et al. Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation. Br J Cancer 79, 1227–1233 (1999). https://doi.org/10.1038/sj.bjc.6690197
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690197
Keywords
This article is cited by
-
Patients’ acceptance of a shared cancer follow-up model of care between general practitioners and radiation oncologists: A population-based survey using the theoretical Framework of Acceptability
BMC Primary Care (2023)
-
Cost-effectiveness of general practitioner- versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial
Journal of Cancer Survivorship (2023)
-
The integration of primary care and childhood cancer survivorship care: a scoping review
Journal of Cancer Survivorship (2022)
-
Survivorship care for cancer patients in primary versus secondary care: a systematic review
Journal of Cancer Survivorship (2021)
-
How breast cancer treatments affect the quality of life of women with non-metastatic breast cancer one year after surgical treatment: a cross-sectional study in Greece
BMC Surgery (2020)